The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia

BACKGROUND: The introduction of direct-acting antivirals (DAA) to treat the hepatitis C virus (HCV) overcame many drawbacks of interferon-based therapy. DAA achieved sustained viral response (SVR) rates above 90% and overcame many drawbacks of pegylated interferon regimens.The HCV genotype (GT) dist...

Descripción completa

Detalles Bibliográficos
Autores principales: Alarfaj, Sumaiah J., Alzahrani, Abdullah, Alotaibi, Anfal, Almutairi, Malak, Hakami, Mashael, Alhomaid, Njood, Alharthi, Noori, Korayem, Ghazwa B., Alghamdi, Abdullah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649346/
https://www.ncbi.nlm.nih.gov/pubmed/36387341
http://dx.doi.org/10.1016/j.jsps.2022.07.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649346/
https://www.ncbi.nlm.nih.gov/pubmed/36387341
http://dx.doi.org/10.1016/j.jsps.2022.07.005

Ejemplares similares